ECM
AMED

Everence Capital Management’s Amedisys AMED Stock Holding History

Everence Capital Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-2,810
Closed -$329K – 623
2018
Q4 		$329K Hold
2,810
– – 0.08% 273
2018
Q3 		$351K Hold
2,810
– – 0.07% 291
2018
Q2 		$240K Buy
+2,810
New +$206K 0.05% 360

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Everence Capital Management's AMED Position: Q1 2019 in Review

Everence Capital Management sold out of Amedisys (AMED) in Q1 2019, closing a stake of 2,810 shares — an estimated $329K sold.

Everence Capital Management first reported a position in AMED in Q2 2018 and held it in 3 quarters. The position peaked at $351K in Q3 2018. 317 funds tracked by Wall St. Rank hold AMED as of Q1 2019.

  • Everence Capital Management reported no remaining Amedisys position as of Q1 2019 after selling out during the quarter.
  • Everence Capital Management sold 2,810 Amedisys shares in Q1 2019, an estimated $329K.
  • Everence Capital Management first reported a position in Amedisys in Q2 2018 and held it in 3 quarters.
  • Everence Capital Management's Amedisys position peaked at $351K in Q3 2018.
  • 317 funds tracked by Wall St. Rank held Amedisys as of Q1 2019.

Based on Everence Capital Management's 13F filing for Q1 2019, filed 6 May 2019.